Activotec announces further business expansion
Activotec has announced a major expansion of its Cambridge, UK Headquarters and investment in new sales and production staff to meet the demand for its Activo-P11 Peptide Synthesize.
Chris Littlewood, Chief Executive of Activotec, commented "2008 peptide synthesizer sales have exceeded even our most optimistic expectations". He added "We are the only European company with international service and support teams that are exclusively focused on peptide synthesis instrumentation and services. This enables Activotec to be uniquely positioned to provide customers with informed technical assistance enabling them to get the most from their peptide synthesizer".
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.